nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—CYP2C19—Methimazole—Graves' disease	0.207	0.546	CbGbCtD
Ibuprofen—CYP2C9—Methimazole—Graves' disease	0.172	0.454	CbGbCtD
Ibuprofen—Glomerulonephritis—Propylthiouracil—Graves' disease	0.0493	0.132	CcSEcCtD
Ibuprofen—Nephritis—Methimazole—Graves' disease	0.031	0.083	CcSEcCtD
Ibuprofen—Nephritis—Propylthiouracil—Graves' disease	0.0263	0.0705	CcSEcCtD
Ibuprofen—Neuritis—Methimazole—Graves' disease	0.0142	0.038	CcSEcCtD
Ibuprofen—Neuritis—Propylthiouracil—Graves' disease	0.0121	0.0323	CcSEcCtD
Ibuprofen—Aplastic anaemia—Methimazole—Graves' disease	0.00994	0.0266	CcSEcCtD
Ibuprofen—Vasculitis—Propylthiouracil—Graves' disease	0.00922	0.0247	CcSEcCtD
Ibuprofen—Lymphadenopathy—Methimazole—Graves' disease	0.00901	0.0241	CcSEcCtD
Ibuprofen—Aplastic anaemia—Propylthiouracil—Graves' disease	0.00845	0.0226	CcSEcCtD
Ibuprofen—Lymphadenopathy—Propylthiouracil—Graves' disease	0.00766	0.0205	CcSEcCtD
Ibuprofen—Hepatic failure—Propylthiouracil—Graves' disease	0.00727	0.0195	CcSEcCtD
Ibuprofen—Renal failure acute—Propylthiouracil—Graves' disease	0.00708	0.0189	CcSEcCtD
Ibuprofen—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.00692	0.0185	CcSEcCtD
Ibuprofen—THBD—pituitary gland—Graves' disease	0.00685	0.0717	CbGeAlD
Ibuprofen—THBD—adipose tissue—Graves' disease	0.00682	0.0714	CbGeAlD
Ibuprofen—PLAT—eye—Graves' disease	0.0065	0.0681	CbGeAlD
Ibuprofen—BCL2—connective tissue—Graves' disease	0.00626	0.0656	CbGeAlD
Ibuprofen—Drowsiness—Methimazole—Graves' disease	0.00592	0.0159	CcSEcCtD
Ibuprofen—THBD—thyroid gland—Graves' disease	0.0059	0.0618	CbGeAlD
Ibuprofen—Neuropathy peripheral—Methimazole—Graves' disease	0.0058	0.0155	CcSEcCtD
Ibuprofen—Jaundice—Methimazole—Graves' disease	0.00577	0.0155	CcSEcCtD
Ibuprofen—Agranulocytosis—Methimazole—Graves' disease	0.00553	0.0148	CcSEcCtD
Ibuprofen—Hepatitis—Methimazole—Graves' disease	0.00532	0.0142	CcSEcCtD
Ibuprofen—Drowsiness—Propylthiouracil—Graves' disease	0.00503	0.0135	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00494	0.0132	CcSEcCtD
Ibuprofen—Jaundice—Propylthiouracil—Graves' disease	0.00491	0.0131	CcSEcCtD
Ibuprofen—PLAT—pituitary gland—Graves' disease	0.00483	0.0505	CbGeAlD
Ibuprofen—PLAT—adipose tissue—Graves' disease	0.00481	0.0503	CbGeAlD
Ibuprofen—Agranulocytosis—Propylthiouracil—Graves' disease	0.0047	0.0126	CcSEcCtD
Ibuprofen—Alopecia—Methimazole—Graves' disease	0.0047	0.0126	CcSEcCtD
Ibuprofen—Haemoglobin—Propylthiouracil—Graves' disease	0.00454	0.0122	CcSEcCtD
Ibuprofen—Hepatitis—Propylthiouracil—Graves' disease	0.00452	0.0121	CcSEcCtD
Ibuprofen—Haemorrhage—Propylthiouracil—Graves' disease	0.00452	0.0121	CcSEcCtD
Ibuprofen—CXCL8—pituitary gland—Graves' disease	0.00447	0.0468	CbGeAlD
Ibuprofen—CXCL8—adipose tissue—Graves' disease	0.00445	0.0466	CbGeAlD
Ibuprofen—PLAT—thyroid gland—Graves' disease	0.00416	0.0436	CbGeAlD
Ibuprofen—BCL2—thyroid gland—Graves' disease	0.00416	0.0436	CbGeAlD
Ibuprofen—Vertigo—Methimazole—Graves' disease	0.00416	0.0111	CcSEcCtD
Ibuprofen—Leukopenia—Methimazole—Graves' disease	0.00414	0.0111	CcSEcCtD
Ibuprofen—Alopecia—Propylthiouracil—Graves' disease	0.00399	0.0107	CcSEcCtD
Ibuprofen—Myalgia—Methimazole—Graves' disease	0.00394	0.0105	CcSEcCtD
Ibuprofen—Arthralgia—Methimazole—Graves' disease	0.00394	0.0105	CcSEcCtD
Ibuprofen—Dysgeusia—Propylthiouracil—Graves' disease	0.00385	0.0103	CcSEcCtD
Ibuprofen—Oedema—Methimazole—Graves' disease	0.00378	0.0101	CcSEcCtD
Ibuprofen—Thrombocytopenia—Methimazole—Graves' disease	0.0037	0.0099	CcSEcCtD
Ibuprofen—Vertigo—Propylthiouracil—Graves' disease	0.00353	0.00947	CcSEcCtD
Ibuprofen—Leukopenia—Propylthiouracil—Graves' disease	0.00352	0.00943	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00344	0.00921	CcSEcCtD
Ibuprofen—Paraesthesia—Methimazole—Graves' disease	0.00339	0.00908	CcSEcCtD
Ibuprofen—Somnolence—Methimazole—Graves' disease	0.00336	0.00899	CcSEcCtD
Ibuprofen—Arthralgia—Propylthiouracil—Graves' disease	0.00335	0.00897	CcSEcCtD
Ibuprofen—Myalgia—Propylthiouracil—Graves' disease	0.00335	0.00897	CcSEcCtD
Ibuprofen—Dyspepsia—Methimazole—Graves' disease	0.00332	0.0089	CcSEcCtD
Ibuprofen—Oedema—Propylthiouracil—Graves' disease	0.00321	0.0086	CcSEcCtD
Ibuprofen—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00314	0.00842	CcSEcCtD
Ibuprofen—PPARG—connective tissue—Graves' disease	0.00301	0.0315	CbGeAlD
Ibuprofen—Urticaria—Methimazole—Graves' disease	0.003	0.00803	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00293	0.00783	CcSEcCtD
Ibuprofen—Paraesthesia—Propylthiouracil—Graves' disease	0.00288	0.00772	CcSEcCtD
Ibuprofen—Somnolence—Propylthiouracil—Graves' disease	0.00285	0.00764	CcSEcCtD
Ibuprofen—Dyspepsia—Propylthiouracil—Graves' disease	0.00283	0.00757	CcSEcCtD
Ibuprofen—SLC22A8—eye—Graves' disease	0.00281	0.0295	CbGeAlD
Ibuprofen—Pruritus—Methimazole—Graves' disease	0.00267	0.00715	CcSEcCtD
Ibuprofen—Urticaria—Propylthiouracil—Graves' disease	0.00255	0.00683	CcSEcCtD
Ibuprofen—Vomiting—Methimazole—Graves' disease	0.0024	0.00643	CcSEcCtD
Ibuprofen—Rash—Methimazole—Graves' disease	0.00238	0.00638	CcSEcCtD
Ibuprofen—Dermatitis—Methimazole—Graves' disease	0.00238	0.00637	CcSEcCtD
Ibuprofen—SLCO2B1—adipose tissue—Graves' disease	0.00237	0.0248	CbGeAlD
Ibuprofen—Headache—Methimazole—Graves' disease	0.00237	0.00634	CcSEcCtD
Ibuprofen—PPARG—adipose tissue—Graves' disease	0.00231	0.0242	CbGeAlD
Ibuprofen—Pruritus—Propylthiouracil—Graves' disease	0.00227	0.00608	CcSEcCtD
Ibuprofen—Nausea—Methimazole—Graves' disease	0.00224	0.00601	CcSEcCtD
Ibuprofen—ABCC4—adipose tissue—Graves' disease	0.0021	0.022	CbGeAlD
Ibuprofen—SLCO2B1—thyroid gland—Graves' disease	0.00205	0.0215	CbGeAlD
Ibuprofen—Vomiting—Propylthiouracil—Graves' disease	0.00204	0.00547	CcSEcCtD
Ibuprofen—Rash—Propylthiouracil—Graves' disease	0.00202	0.00542	CcSEcCtD
Ibuprofen—Dermatitis—Propylthiouracil—Graves' disease	0.00202	0.00542	CcSEcCtD
Ibuprofen—Headache—Propylthiouracil—Graves' disease	0.00201	0.00539	CcSEcCtD
Ibuprofen—PPARG—thyroid gland—Graves' disease	0.002	0.0209	CbGeAlD
Ibuprofen—Nausea—Propylthiouracil—Graves' disease	0.00191	0.00511	CcSEcCtD
Ibuprofen—ABCC4—thyroid gland—Graves' disease	0.00181	0.019	CbGeAlD
Ibuprofen—ABCC1—pituitary gland—Graves' disease	0.0018	0.0188	CbGeAlD
Ibuprofen—ABCC1—adipose tissue—Graves' disease	0.00179	0.0187	CbGeAlD
Ibuprofen—PTGS1—connective tissue—Graves' disease	0.00161	0.0169	CbGeAlD
Ibuprofen—ABCC1—thyroid gland—Graves' disease	0.00155	0.0162	CbGeAlD
Ibuprofen—PTGS2—connective tissue—Graves' disease	0.00154	0.0161	CbGeAlD
Ibuprofen—CYP2C8—pituitary gland—Graves' disease	0.00153	0.016	CbGeAlD
Ibuprofen—PTGS1—pituitary gland—Graves' disease	0.00124	0.013	CbGeAlD
Ibuprofen—PTGS1—adipose tissue—Graves' disease	0.00123	0.0129	CbGeAlD
Ibuprofen—BCL2—IL2-mediated signaling events—IL2RA—Graves' disease	0.0012	0.00786	CbGpPWpGaD
Ibuprofen—BCL2—Caspase Cascade in Apoptosis—FASLG—Graves' disease	0.00119	0.00785	CbGpPWpGaD
Ibuprofen—PTGS2—pituitary gland—Graves' disease	0.00118	0.0124	CbGeAlD
Ibuprofen—PTGS2—adipose tissue—Graves' disease	0.00118	0.0124	CbGeAlD
Ibuprofen—BCL2—Overview of nanoparticle effects—TNF—Graves' disease	0.00118	0.00774	CbGpPWpGaD
Ibuprofen—PLAT—Selenium Micronutrient Network—ICAM1—Graves' disease	0.00117	0.00768	CbGpPWpGaD
Ibuprofen—BCL2—Caspase Cascade in Apoptosis—FAS—Graves' disease	0.00115	0.00757	CbGpPWpGaD
Ibuprofen—CXCL8—Overview of nanoparticle effects—TNF—Graves' disease	0.00113	0.00744	CbGpPWpGaD
Ibuprofen—PLAT—Folate Metabolism—IFNG—Graves' disease	0.00112	0.00736	CbGpPWpGaD
Ibuprofen—PTGS1—thyroid gland—Graves' disease	0.00107	0.0112	CbGeAlD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.00101	0.00665	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—HLA-DQB1—Graves' disease	0.00101	0.00662	CbGpPWpGaD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.001	0.0066	CbGpPWpGaD
Ibuprofen—PLAT—Folate Metabolism—IL1B—Graves' disease	0.000999	0.00656	CbGpPWpGaD
Ibuprofen—CXCL8—EBV LMP1 signaling—TNF—Graves' disease	0.000972	0.00638	CbGpPWpGaD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.000963	0.00633	CbGpPWpGaD
Ibuprofen—CXCL8—AP-1 transcription factor network—HLA-A—Graves' disease	0.000923	0.00607	CbGpPWpGaD
Ibuprofen—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.000917	0.00602	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—HLA-B—Graves' disease	0.000905	0.00595	CbGpPWpGaD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.000904	0.00594	CbGpPWpGaD
Ibuprofen—PLAT—Vitamin B12 Metabolism—TNF—Graves' disease	0.000891	0.00585	CbGpPWpGaD
Ibuprofen—PLAT—Selenium Micronutrient Network—IFNG—Graves' disease	0.00089	0.00585	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—FASLG—Graves' disease	0.000884	0.00581	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—FASLG—Graves' disease	0.000876	0.00576	CbGpPWpGaD
Ibuprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—Graves' disease	0.000864	0.00568	CbGpPWpGaD
Ibuprofen—PLAT—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000863	0.00567	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—FAS—Graves' disease	0.000853	0.0056	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—IL2RA—Graves' disease	0.000848	0.00557	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—FAS—Graves' disease	0.000845	0.00555	CbGpPWpGaD
Ibuprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000845	0.00555	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—HLA-A—Graves' disease	0.000838	0.00551	CbGpPWpGaD
Ibuprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.000828	0.00544	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis Modulation and Signaling—FASLG—Graves' disease	0.000822	0.0054	CbGpPWpGaD
Ibuprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000806	0.0053	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—CXCL10—Graves' disease	0.000805	0.00529	CbGpPWpGaD
Ibuprofen—PLAT—Selenium Micronutrient Network—IL1B—Graves' disease	0.000793	0.00521	CbGpPWpGaD
Ibuprofen—PPARG—Transcription factor regulation in adipogenesis—TNF—Graves' disease	0.000793	0.00521	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis Modulation and Signaling—FAS—Graves' disease	0.000792	0.00521	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.00079	0.00519	CbGpPWpGaD
Ibuprofen—BCL2—IL2-mediated signaling events—IFNG—Graves' disease	0.000789	0.00519	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.000773	0.00508	CbGpPWpGaD
Ibuprofen—PLAT—Senescence and Autophagy in Cancer—IFNG—Graves' disease	0.000772	0.00508	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—HLA-DRB1—Graves' disease	0.000766	0.00503	CbGpPWpGaD
Ibuprofen—THBD—Hemostasis—IL2RA—Graves' disease	0.000764	0.00502	CbGpPWpGaD
Ibuprofen—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Graves' disease	0.000757	0.00498	CbGpPWpGaD
Ibuprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000753	0.00495	CbGpPWpGaD
Ibuprofen—BCL2—ATF-2 transcription factor network—IFNG—Graves' disease	0.000735	0.00483	CbGpPWpGaD
Ibuprofen—ABCB1—pituitary gland—Graves' disease	0.000733	0.00768	CbGeAlD
Ibuprofen—ABCB1—adipose tissue—Graves' disease	0.00073	0.00764	CbGeAlD
Ibuprofen—PLAT—Folate Metabolism—TNF—Graves' disease	0.000725	0.00476	CbGpPWpGaD
Ibuprofen—CXCL8—Glucocorticoid receptor regulatory network—ICAM1—Graves' disease	0.000713	0.00469	CbGpPWpGaD
Ibuprofen—BCL2—DNA Damage Response (only ATM dependent)—FASLG—Graves' disease	0.000711	0.00467	CbGpPWpGaD
Ibuprofen—CXCL8—ATF-2 transcription factor network—IFNG—Graves' disease	0.000706	0.00464	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.000706	0.00464	CbGpPWpGaD
Ibuprofen—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.000694	0.00456	CbGpPWpGaD
Ibuprofen—PLAT—Senescence and Autophagy in Cancer—IL1B—Graves' disease	0.000689	0.00453	CbGpPWpGaD
Ibuprofen—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—Graves' disease	0.000677	0.00445	CbGpPWpGaD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000635	0.00417	CbGpPWpGaD
Ibuprofen—ABCB1—thyroid gland—Graves' disease	0.000632	0.00662	CbGeAlD
Ibuprofen—PTGS1—Overview of nanoparticle effects—TNF—Graves' disease	0.000625	0.0041	CbGpPWpGaD
Ibuprofen—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—Graves' disease	0.000624	0.0041	CbGpPWpGaD
Ibuprofen—CXCL8—AP-1 transcription factor network—IFNG—Graves' disease	0.000616	0.00405	CbGpPWpGaD
Ibuprofen—SLCO2B1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000589	0.00387	CbGpPWpGaD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000584	0.00383	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000584	0.00383	CbGpPWpGaD
Ibuprofen—PLAT—Selenium Micronutrient Network—TNF—Graves' disease	0.000576	0.00378	CbGpPWpGaD
Ibuprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000571	0.00375	CbGpPWpGaD
Ibuprofen—BCL2—Direct p53 effectors—FAS—Graves' disease	0.000561	0.00369	CbGpPWpGaD
Ibuprofen—BCL2—Ceramide signaling pathway—TNF—Graves' disease	0.000561	0.00369	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—IFNG—Graves' disease	0.000559	0.00368	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000559	0.00367	CbGpPWpGaD
Ibuprofen—CXCL8—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.00055	0.00361	CbGpPWpGaD
Ibuprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000547	0.00359	CbGpPWpGaD
Ibuprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.000546	0.00359	CbGpPWpGaD
Ibuprofen—CXCL8—Glucocorticoid receptor regulatory network—IFNG—Graves' disease	0.000543	0.00357	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—FASLG—Graves' disease	0.000537	0.00353	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.000535	0.00352	CbGpPWpGaD
Ibuprofen—BCL2—C-MYB transcription factor network—CD4—Graves' disease	0.000535	0.00352	CbGpPWpGaD
Ibuprofen—SLC22A11—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000533	0.00351	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—ICAM1—Graves' disease	0.000533	0.0035	CbGpPWpGaD
Ibuprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000522	0.00343	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000521	0.00342	CbGpPWpGaD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000521	0.00342	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—FAS—Graves' disease	0.000518	0.0034	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—IL1B—Graves' disease	0.000499	0.00328	CbGpPWpGaD
Ibuprofen—PTGS2—Overview of nanoparticle effects—TNF—Graves' disease	0.000496	0.00326	CbGpPWpGaD
Ibuprofen—BCL2—Caspase Cascade in Apoptosis—TNF—Graves' disease	0.000489	0.00321	CbGpPWpGaD
Ibuprofen—CXCL8—G alpha (i) signalling events—CXCL10—Graves' disease	0.000464	0.00305	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—IFNG—Graves' disease	0.000464	0.00305	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—GC—Graves' disease	0.000459	0.00302	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000454	0.00298	CbGpPWpGaD
Ibuprofen—PPARG—Adipogenesis—FAS—Graves' disease	0.000451	0.00296	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—IFNG—Graves' disease	0.000445	0.00293	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000444	0.00292	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000438	0.00288	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR ligand binding—TSHR—Graves' disease	0.000435	0.00286	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—IL1B—Graves' disease	0.000413	0.00272	CbGpPWpGaD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000411	0.0027	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000409	0.00269	CbGpPWpGaD
Ibuprofen—SLC22A8—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000407	0.00267	CbGpPWpGaD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.000407	0.00267	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—IFNG—Graves' disease	0.000406	0.00267	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—IL1B—Graves' disease	0.000397	0.00261	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.000394	0.00259	CbGpPWpGaD
Ibuprofen—ABCC4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00039	0.00256	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—CD40—Graves' disease	0.000385	0.00253	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000381	0.00251	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.00038	0.0025	CbGpPWpGaD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000378	0.00248	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000378	0.00248	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000372	0.00245	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.00037	0.00243	CbGpPWpGaD
Ibuprofen—CXCL8—Metabolism of proteins—B3GNT2—Graves' disease	0.000369	0.00242	CbGpPWpGaD
Ibuprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000369	0.00242	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000368	0.00242	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—TNF—Graves' disease	0.000362	0.00238	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—IL1B—Graves' disease	0.000362	0.00238	CbGpPWpGaD
Ibuprofen—SLCO1A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000361	0.00237	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—TNF—Graves' disease	0.000359	0.00236	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000353	0.00232	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—CXCL10—Graves' disease	0.000352	0.00232	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—B3GNT2—Graves' disease	0.000348	0.00229	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—IFIH1—Graves' disease	0.000342	0.00225	CbGpPWpGaD
Ibuprofen—SLC22A6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000339	0.00223	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—IL2RA—Graves' disease	0.000333	0.00219	CbGpPWpGaD
Ibuprofen—ABCC1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000325	0.00214	CbGpPWpGaD
Ibuprofen—PPARG—Circadian rythm related genes—FAS—Graves' disease	0.000318	0.00209	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000317	0.00209	CbGpPWpGaD
Ibuprofen—PPARG—Signaling events mediated by HDAC Class I—TNF—Graves' disease	0.000314	0.00206	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.000313	0.00206	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000311	0.00204	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—ICAM1—Graves' disease	0.000301	0.00198	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000295	0.00194	CbGpPWpGaD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000295	0.00194	CbGpPWpGaD
Ibuprofen—ABCC4—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000292	0.00192	CbGpPWpGaD
Ibuprofen—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—Graves' disease	0.000291	0.00191	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000289	0.0019	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—IFNG—Graves' disease	0.000283	0.00186	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000281	0.00185	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—HLA-B—Graves' disease	0.000281	0.00185	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR ligand binding—CXCL10—Graves' disease	0.000281	0.00185	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—FASLG—Graves' disease	0.000275	0.0018	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—HLA-E—Graves' disease	0.000269	0.00177	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—FAS—Graves' disease	0.000265	0.00174	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IL2RA—Graves' disease	0.000263	0.00173	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—TNF—Graves' disease	0.000263	0.00173	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.00026	0.00171	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—IL1B—Graves' disease	0.000253	0.00166	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000251	0.00165	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000247	0.00162	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—GC—Graves' disease	0.000246	0.00162	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—TSHR—Graves' disease	0.000246	0.00161	CbGpPWpGaD
Ibuprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000244	0.00161	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000239	0.00157	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000238	0.00156	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—ICAM1—Graves' disease	0.000234	0.00154	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.00023	0.00151	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—IFNG—Graves' disease	0.000229	0.0015	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000229	0.0015	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—TSHR—Graves' disease	0.000228	0.0015	CbGpPWpGaD
Ibuprofen—PTGS2—C-MYB transcription factor network—CD4—Graves' disease	0.000225	0.00148	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—IFNG—Graves' disease	0.000225	0.00148	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—TSHR—Graves' disease	0.000223	0.00147	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—TNF—Graves' disease	0.00022	0.00144	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—TNF—Graves' disease	0.00021	0.00138	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—GC—Graves' disease	0.000209	0.00137	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—IL1B—Graves' disease	0.000204	0.00134	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000201	0.00132	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—IL1B—Graves' disease	0.0002	0.00132	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.0002	0.00131	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IFIH1—Graves' disease	0.000199	0.00131	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—GC—Graves' disease	0.000198	0.0013	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—HLA-B—Graves' disease	0.000192	0.00126	CbGpPWpGaD
Ibuprofen—PPARG—Adipogenesis—TNF—Graves' disease	0.000191	0.00126	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000191	0.00126	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—B3GNT2—Graves' disease	0.000186	0.00122	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000186	0.00122	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000184	0.00121	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—TNF—Graves' disease	0.000183	0.0012	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—TNF—Graves' disease	0.000182	0.0012	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—GC—Graves' disease	0.000182	0.0012	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—IFNG—Graves' disease	0.000182	0.00119	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000179	0.00118	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—IFNG—Graves' disease	0.000178	0.00117	CbGpPWpGaD
Ibuprofen—ALB—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000176	0.00116	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.000174	0.00114	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—GC—Graves' disease	0.00017	0.00112	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—GC—Graves' disease	0.00017	0.00112	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—GC—Graves' disease	0.000164	0.00108	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000163	0.00107	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—IL1B—Graves' disease	0.000162	0.00107	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—CXCL10—Graves' disease	0.000159	0.00104	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—IL1B—Graves' disease	0.000159	0.00104	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—B3GNT2—Graves' disease	0.000158	0.00104	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-E—Graves' disease	0.000157	0.00103	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IL1B—Graves' disease	0.000155	0.00102	CbGpPWpGaD
Ibuprofen—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000155	0.00102	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD40—Graves' disease	0.000153	0.00101	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CTLA4—Graves' disease	0.000151	0.000993	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—IL2RA—Graves' disease	0.00015	0.000988	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—B3GNT2—Graves' disease	0.00015	0.000984	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—B3GNT2—Graves' disease	0.000148	0.000974	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—TNF—Graves' disease	0.000148	0.000974	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—CXCL10—Graves' disease	0.000148	0.00097	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—TNF—Graves' disease	0.000145	0.000956	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CXCL10—Graves' disease	0.000144	0.000947	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—GC—Graves' disease	0.000138	0.00091	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—B3GNT2—Graves' disease	0.000138	0.000906	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000136	0.000891	CbGpPWpGaD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000132	0.000867	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TSHR—Graves' disease	0.000132	0.000866	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000131	0.000859	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—B3GNT2—Graves' disease	0.000129	0.000846	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—B3GNT2—Graves' disease	0.000129	0.000846	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-DQB1—Graves' disease	0.000124	0.000818	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—B3GNT2—Graves' disease	0.000124	0.000815	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—IL2RA—Graves' disease	0.000121	0.000797	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—TNF—Graves' disease	0.000118	0.000773	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD8A—Graves' disease	0.000116	0.000763	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—TNF—Graves' disease	0.000115	0.000756	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—CD4—Graves' disease	0.000115	0.000753	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—IL2RA—Graves' disease	0.000113	0.000741	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—TNF—Graves' disease	0.000112	0.000739	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-B—Graves' disease	0.000112	0.000734	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—IL2RA—Graves' disease	0.00011	0.000724	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—GC—Graves' disease	0.00011	0.000722	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—B3GNT2—Graves' disease	0.000105	0.000689	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL2RA—Graves' disease	0.000105	0.000688	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-A—Graves' disease	0.000104	0.00068	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—B3GNT2—Graves' disease	9.94e-05	0.000654	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-DRB1—Graves' disease	9.46e-05	0.000622	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—ICAM1—Graves' disease	9.08e-05	0.000597	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GC—Graves' disease	8.94e-05	0.000588	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GC—Graves' disease	8.89e-05	0.000584	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CXCL10—Graves' disease	8.51e-05	0.000559	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—B3GNT2—Graves' disease	8.33e-05	0.000547	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GC—Graves' disease	7.98e-05	0.000524	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	7.83e-05	0.000514	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GC—Graves' disease	7.79e-05	0.000512	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GC—Graves' disease	7.28e-05	0.000478	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IFNG—Graves' disease	6.91e-05	0.000454	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—IL2RA—Graves' disease	6.8e-05	0.000447	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—B3GNT2—Graves' disease	6.78e-05	0.000445	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—B3GNT2—Graves' disease	6.74e-05	0.000443	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD4—Graves' disease	6.67e-05	0.000438	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—TNF—Graves' disease	6.58e-05	0.000432	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—IL2RA—Graves' disease	6.51e-05	0.000428	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL1B—Graves' disease	6.16e-05	0.000405	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—B3GNT2—Graves' disease	6.05e-05	0.000397	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—HLA-A—Graves' disease	6e-05	0.000394	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—B3GNT2—Graves' disease	5.9e-05	0.000388	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	5.55e-05	0.000365	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—B3GNT2—Graves' disease	5.52e-05	0.000362	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HLA-A—Graves' disease	4.02e-05	0.000264	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CD4—Graves' disease	3.86e-05	0.000254	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CD4—Graves' disease	2.59e-05	0.00017	CbGpPWpGaD
